These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9736928)

  • 1. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS; Zorn SH; Sanner MA; Fliri A
    Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent.
    Belliotti TR; Wustrow DJ; Brink WA; Zoski KT; Shih YH; Whetzel SZ; Georgic LM; Corbin AE; Akunne HC; Heffner TG; Pugsley TA; Wise LD
    J Med Chem; 1999 Dec; 42(25):5181-7. PubMed ID: 10602703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ; Kramer MS; Kulagowski J; Patel S; Ragan CI; Seabrook GR
    Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
    Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D
    Jeffries DE; Witt JO; McCollum AL; Temple KJ; Hurtado MA; Harp JM; Blobaum AL; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5757-5764. PubMed ID: 28327307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
    Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK; Ninan I
    Fundam Clin Pharmacol; 2000; 14(6):529-39. PubMed ID: 11206702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.
    Cao BJ; Rodgers RJ
    Eur J Pharmacol; 1997 Sep; 335(2-3):117-25. PubMed ID: 9369363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA; Evans DL; Stratman NC; Figur LM
    Eur J Pharmacol; 1993 Jun; 236(3):483-6. PubMed ID: 8102973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D2 receptor: love it and leave it.
    Pickar D
    Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P; Corbett R; Van Tol HH
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile.
    Okuyama S; Kawashima N; Chaki S; Yoshikawa R; Funakoshi T; Ogawa SI; Suzuki Y; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    Life Sci; 1999; 65(20):2109-25. PubMed ID: 10579464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
    Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
    J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Trends Pharmacol Sci; 1994 Jul; 15(7):264-70. PubMed ID: 7940991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D4 receptors: curiouser and curiouser.
    Strange PG
    Trends Pharmacol Sci; 1994 Sep; 15(9):317-9. PubMed ID: 7992381
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
    Jardemark K; Wadenberg ML; Grillner P; Svensson TH
    Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.